Edelweiss' research report on PI Industries
Domestic revenue grew 13% (H1FY18: down 5% YoY) bolstered by post GST demand and launch of new products. According to management, Nominee Gold’s performance was in line with expectation; despite heightened competition, which impacted pricing, the product’s revenue grew YoY driven by higher volumes. During the quarter, PI launched 2 new products: Humesol and Visma and plans to launch 5 products in FY18. Post a subdued Q1FY18, growth picked up in Q2FY18 and management maintained 10% FY18 growth guidance in domestic segment.
Outlook
Despite the muted performance in H1FY18, PI maintained its growth guidance for CSM and domestic businesses at 10% each. Given the visibility on CSM and improved domestic performance (Nominee Gold also stable), we maintain our revenue estimates. However, we revise down EBITDA margin on weak performance in H1FY18, leading to 6% and 2% cut in FY18E and FY19E EPS, respectively. We maintain our FY19E target P/E at 25.0x, leading to target price of INR 944. We maintain ‘BUY’.
For all recommendations report, click here
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.